Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Suisse (CSUI) EBITDA Margin (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed EBITDA Margin for 8 consecutive years, with 876.36% as the latest value for Q1 2025.

  • Quarterly EBITDA Margin fell 5236.0% to 876.36% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 3681.81% through Nov 2025, down 265341.0% year-over-year, with the annual reading at 1261.2% for FY2025, 41889.0% down from the prior year.
  • EBITDA Margin for Q1 2025 was 876.36% at Cannabis Suisse, up from 1216.64% in the prior quarter.
  • The five-year high for EBITDA Margin was 524.7% in Q4 2021, with the low at 6199.64% in Q1 2023.
  • Average EBITDA Margin over 4 years is 1399.72%, with a median of 851.61% recorded in 2023.
  • The sharpest move saw EBITDA Margin plummeted -139436bps in 2021, then skyrocketed 537564bps in 2024.
  • Over 4 years, EBITDA Margin stood at 524.7% in 2021, then decreased by -26bps to 661.88% in 2023, then crashed by -84bps to 1216.64% in 2024, then grew by 28bps to 876.36% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 876.36%, 1216.64%, and 983.71% for Q1 2025, Q4 2024, and Q3 2024 respectively.